Nike, Under Armour Shares Climb

UPI Top Stories |


Nike  (NKE) and Under Armour  (UA) shares climbed Thursday along with other athletic retailers, continuing a year-long trend.

The Oregon-based Nike faced controversy over its decision this month to feature NFL player Colin Kaepernick, began kneeling during the national anthem in 2016 to protest police brutality, in an advertisement celebrating the 30th anniversary of the brand's "Just Do It" motto.

Nike shares faced a 3.2 percent drop from the release of the ad campaign, but this since has been erased, as the company made gains through media exposure.

Apex Marketing Group estimates put the value of media exposure from the ad campaign at more than $163 million, Bloomberg reported.

Nike shares were up .94 percent Thursday following its shares hitting a record earlier in the week. Overall, this year Nike shares are up 35 percent with confidence growing in digital sales, according to analysts.

"I thought Nike would have problems with the Kaepernick situation. I was wrong," said Eric Aanes, president and founder of Titus Wealth Management. "Their edgy marketing appeared to pay off for them."

Under Armour shares have similarly climbed 30 percent this year.

Still, the Baltimore-based sportswear company is struggling to regain its financial footing.

On Thursday, Under Armour announced its restructuring plan would cost more than initially expected.

The company now projects restructuring costs of $200 million to $220 million, up from previously expected costs of $190 million to $210 million.

"Following further evaluation, the company has identified approximately $10 million of cash severance charges related to an approximate 3 percent reduction in its global workforce," company's statement said.

The restructuring plan is based on Under Armour's slipping sales in North America.

Although some analysts have concerns about competition from e-commerce hurting sportswear companies, other companies have managed stock market gains this year, including Adidas in Europe with a 25 percent gain for the year and Puma with an 18 percent gain.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
UA Under Armour Inc. Class C 17.56 -0.35 -1.95 1,292,191 Trade
NKE Nike Inc. 76.48 -1.00 -1.29 6,816,903 Trade

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.